Syfovre
Apellis’ GA Drug Syfovre Displays Signs of Recovery Amid Challenges
Anika Sharma
Apellis Pharmaceuticals, which recently faced workforce reductions due to concerns surrounding its groundbreaking geographic atrophy (GA) drug, Syfovre, is reporting ...
Apellis Investigates Needle Issues Amid Search for Syfovre’s Side Effect Origins
Anika Sharma
Apellis, a pharmaceutical company, is zeroing in on a possible source of a rare but severe side effect associated with ...
Apellis’ Syfovre Linked to Eye Inflammation in Geographic Atrophy Patients
SG Tylor
Source – Apellis Pharmaceuticals July 17, After receiving FDA approval for the treatment of advanced eye disease geographic atrophy, Apellis ...
